A breeder in rural Montana couldn't afford to fly her dogs to a specialist for OFA cardiac evaluations. The nearest board-certified cardiologist was 400 miles away. That travel cost — added to the exam fee — made cardiac certification economically impossible for her small program. In 2026, she uses an AI-powered remote cardiac screening system. Her vet uploads the data. The analysis comes back in hours. The result is submitted to OFA. Distance is no longer the barrier it was. For the dogs this breeder produces, that matters enormously.

AI is no longer a theoretical concept in veterinary medicine. It is actively changing how dogs are screened, diagnosed, and treated. Here's what's real, what's coming, and what it means for breeders and buyers right now.

Hip Dysplasia: Where AI Is Making the Biggest Impact Today

Hip dysplasia remains one of the most common and costly heritable conditions in dogs, affecting an estimated 20% of large breeds and causing millions of dollars in veterinary costs and incalculable suffering every year. Early detection is critical — both for treating affected dogs and for removing affected dogs from breeding programs.

Traditional OFA hip evaluation requires radiographs submitted for evaluation by a panel of veterinary radiologists. The process takes days to weeks. The PennHIP method, developed at the University of Pennsylvania, provides a more objective distraction index measurement — but requires certified practitioners and specialized positioning.

AI-assisted radiograph analysis, now being used by several veterinary imaging services, can assess hip conformation metrics within minutes. Studies published in 2024 and 2025 show AI systems achieving diagnostic accuracy comparable to board-certified radiologists for standard hip conformation assessment. This isn't replacing OFA — it's making preliminary screening faster and more accessible, allowing breeders to screen more dogs more often, and helping general practice vets identify cases that warrant specialist referral.

Cardiac Screening: Remote Assessment Arrives

Congenital cardiac conditions — including Dilated Cardiomyopathy (DCM) in Dobermans and Boxers, Mitral Valve Disease in Cavalier King Charles Spaniels, and Subvalvular Aortic Stenosis in Newfoundlands — are among the most devastating heritable health problems in specific breeds.

Traditional OFA cardiac certification requires in-person examination by a board-certified cardiologist. For breeders in rural areas, this creates genuine access barriers. Remote cardiac auscultation systems — using high-quality digital stethoscopes with AI analysis of the audio signal — have reached sufficient accuracy for preliminary screening in research settings, with clinical deployment accelerating through 2025 and into 2026.

What this means for buyers: the geographic excuse for lacking cardiac certification is shrinking. In 2026, a breeder who doesn't cardiac-certify their breeding dogs is making a choice, not navigating an insurmountable barrier.

Don't Guess. Check.

Before you send money, before you fall in love, before you bring a dog home — check the record. Search 1,700+ breeders, rescues, and shelters.

Check the Record

Genetic Testing: From Single Variants to Full Genomic Profiles

Canine genetic testing has transformed in the past five years. What was once a series of expensive individual tests — one gene at a time — is now available as comprehensive panels covering hundreds of disease markers, traits, and drug sensitivities for $100 to $250 per dog.

AI is driving two advances in this space. First, interpretation: genomic panels generate enormous amounts of data, and AI systems are increasingly capable of synthesizing that data into actionable breeding recommendations — identifying which pairings are safe, which carry double risk, and which combinations produce the lowest heritable disease load in offspring.

Second, discovery: with access to large canine genomic datasets, AI is accelerating the identification of new disease-associated variants. Conditions that had no known genetic marker five years ago may have one today. Breeders using services connected to these research databases are contributing to — and benefiting from — an expanding library of knowledge.

Wearables and Continuous Monitoring

Canine wearable technology has moved from fitness tracking (steps, calories) to genuine health monitoring. Devices now in use track heart rate variability, respiratory rate, activity patterns, and sleep quality with sufficient precision to detect early indicators of cardiac stress, pain, and metabolic dysfunction.

For breeding dogs, continuous monitoring creates a longitudinal health record that augments snapshot evaluations. A dog that passes a single cardiac exam but shows abnormal heart rate variability patterns over six months of wearable data is a dog whose breeding status warrants reconsideration. This kind of granular, ongoing data collection didn't exist five years ago.

For buyers, this represents a future where a dog's health history isn't just a stack of exam results — it's a continuous timeline. Breeders who invest in this technology and share that data are distinguishing themselves in a meaningful way.

Eye Screening: Automated CAER Analysis

Ophthalmic examination for heritable eye conditions — including Progressive Retinal Atrophy (PRA), hereditary cataracts, and Collie Eye Anomaly — has traditionally required a board-certified ophthalmologist performing a dilated fundus exam. AI-assisted retinal imaging systems are now capable of analyzing fundus photographs with high accuracy for several common conditions.

This does not replace the CAER exam for OFA certification — the certification still requires a board-certified specialist. But AI-assisted preliminary screening allows breeders to identify dogs with likely ophthalmic issues before investing in specialist exams, and may accelerate the process of making CAER-equivalent evaluations more widely accessible in coming years.

What This Means for Buyers Right Now

The expansion of AI-assisted screening tools has one consistent implication: the barriers to health testing are lower than ever. Distance, cost, and wait times — the historically valid reasons some breeders gave for skipping certain tests — are all shrinking.

A breeder producing puppies in 2026 without health testing is not facing the same market realities as a breeder in 2010. The tools exist. The costs are decreasing. The information is available. What's often missing is the will to use them.

When you see a breeder profile with no health testing, ask why. The answer will tell you a great deal about what matters to them — and what should matter to you before you write a check.

Check the DogFacts

The people who check don't regret it. Search any breeder, rescue, or shelter — see what's been shared, see what's missing.

Search Now